Asia
Singapore Exchange-listed Singapore eDevelopment Limited is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California.
Eisai Co., Ltd. announced today that its Chinese subsidiary, Eisai China Inc. (ECI) has commenced full-scale operation of its new Suzhou plant located within the Suzhou Industrial Park, and an opening ceremony was held accordingly.
GE Healthcare partners with Wego to provide locally manufactured single-use consumables for bioprocessing in China
If the company does sell some older assets, it could use the funds to support development of high-growth assets in immuno-oncology.
United Therapeutics bets a significant amount of money on the potential commercialization of ralinepag.
A*STAR scientists successfully grow skin on a credit-card sized device that facilitates testing of pharmaceuticals, cosmetics, and other chemicals; Awarded the Global 3Rs Award for reducing animal use in scientific research
iX Biopharma Ltd will be presenting the positive results from the Phase 2 clinical KET010 study for Wafermine, its lead product under development for the treatment of moderate to severe acute pain at the Bio-Europe 24th Annual International Partnering Conference in Copenhagen, Denmark.
Move to help bolster efforts to position emirate as leading and highly preferred destination for health rejuvenation
Singapore scientists have found a way to evolve fungi commonly found in our gut that could help protect us against different forms of infection
An international team of scientists have confirmed that both rare and common mutations of our genes are linked to the development of breast cancer, including tumour characteristics and corresponding deadliness.
PRESS RELEASES